TRENDS IN DRUG-DRUG INTERACTIONS AMONG US OLDER ADULTS, 2015-2016 VS. 2021-2023
Dima Qato, Shyam Krishnan Ondanat Veetil, Jocelyn Wilder · 2024
Read TRENDS IN DRUG-DRUG INTERACTIONS AMONG US OLDER ADULTS, 2015-2016 VS. 2021-2023 by Dima Qato, Shyam Krishnan Ondanat Veetil, Jocelyn Wilder (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11693059.txt.
Description
Dima Qato, Shyam Krishnan Ondanat Veetil, and Jocelyn Wilder track risky drug pairs in older adults in a 2024 study. Some drug pairs clash and can kill, yet fresh counts of their use are scarce. The team used a national sample of older adults who live at home. Home visits logged each drug in 2015 to 2016 and again in 2021 to 2023. A drug data bank flagged pairs marked avoid or banned.
Risk share fell from 12.3 percent to 10.8 percent across the two spans. Use of clash pairs with aspirin, warfarin, and a strong pain drug all fell. Pairs with some mood, muscle, and asthma drugs rose in the same span. One in nine older adults still sat at risk of a major clash. The authors urge more patient grasp of common clash pairs to cut harm.
Catalog record
| CREATOR | Dima Qato, Shyam Krishnan Ondanat Veetil, Jocelyn Wilder |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |